Have an account? Log in.
I don't have an account.
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and lowers the price target from $67 to $54.
Piper Sandler analyst Adam Maeder downgrades Inspire Medical Systems (NYSE:INSP) from Overweight to Neutral and lowers the price target from $85 to $55.
The Nasdaq 100 surged past 28,000 during Tuesday morning trading, setting a fresh record as AI-driven gains in semiconductor stocks continued to power the broader tech sector, defying pressure from elevated oil prices and geopolitical tension.
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $70 to $65.
RBC Capital analyst Shagun Singh maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perform and lowers the price target from $56 to $45.
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $64 to $50.
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $62 to $55.
Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:INSP) with a Equal-Weight and lowers the price target from $70 to $56.
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $70 to $55.
(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.)
Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and lowers the price target from $63 to $50.
Shares of Sterling Infrastructure Inc (NASDAQ: STRL) jumped 22.5% in pre-market trading after reporting better-than-expected Q1 results and raising its FY26 guidance. Other gainers include BLZE, INHD, EVER, AMOD, PINS, DVLT. Losers include WGS and SKK.
Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 analyst estimate..
Inspire Medical Systems (NYSE:INSP) lowers FY2026 Adj EPS guidance from $1.85-$2.35 to $0.75-$1.25 vs $1.88 analyst estimate. Lowers FY2026 sales outlook from $950.000 million-$1.000 billion to $825.000 million-$875.000
Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.28) by 135.71 percent. This is unchanged from the same period last year. The company
U.S. stocks gave up early gains Tuesday as oil jumped nearly 3%. UnitedHealth surged 8% on strong earnings.
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $85 to $70.
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $85 to $70.
U.S. stocks held modest midday gains Thursday as tentative Lebanon–Israel diplomatic overtures introduced a fragile layer of optimism into an otherwise tense geopolitical backdrop.
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $85 to $62.